Fresh Tracks Therapeutics
Stock Forecast, Prediction & Price Target
Fresh Tracks Therapeutics Financial Estimates
Fresh Tracks Therapeutics Revenue Estimates
Fresh Tracks Therapeutics EBITDA Estimates
Fresh Tracks Therapeutics Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | |||
Revenue
% change YoY
| $404K N/A | $6.94M 1618.56% | $8.00M 15.31% | Avg: $16.8M Low: $16.8M High: $16.8M avg. 109.84% | |||
Net Income
% change YoY
| $-39.52M N/A | $-20.66M 47.72% | $-5.69M 72.44% | Avg: $-4.13M Low: $-4.13M High: $-4.13M avg. 27.31% | |||
EBITDA
% change YoY
| $-40.24M N/A | $-21.09M 47.58% | $-5.64M 73.22% | Avg: $-15.81M Low: $-15.81M High: $-15.81M avg. -179.92% | |||
EPS
% change YoY
| -$22.14 N/A | -$7.36 66.75% | -$0.96 86.95% | Avg: -$0.7 Low: -$0.7 High: -$0.7 avg. 27.08% | |||
Operating Expenses
% change YoY
| $40.64M N/A | $28.47M -29.94% | $14.36M -49.55% | Avg: $141.47M Low: $141.47M High: $141.47M avg. 884.77% | |||
FAQ
What is Fresh Tracks Therapeutics stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 27.31% in 2025-2025.
We have gathered data from N/A analysts. Their low estimate is -4.13M, average is -4.13M and high is -4.13M.
What is Fresh Tracks Therapeutics stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 109.84% in 2025-2025.
We have gathered data from 1 analysts. Their low revenue estimate is $16.8M, average is $16.8M and high is $16.8M.
What is Fresh Tracks Therapeutics stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 27.08% in 2025-2025.
We have gathered data from N/A analysts. Their low earnings per share estimate is -$0.7, average is -$0.7 and high is $-0.7.